PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27679543-0	2016	Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors.	Bleomycin	25-34	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	51-55	
27679543-0	2016	Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors.	Bleomycin	25-34	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	98-102	
27679543-7	2016	Furthermore, the synergistic interaction between vemurafenib and ECT with bleomycin was demonstrated in the BRAF V600E mutated melanoma cells.	Bleomycin	74-83	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	108-112	
23856246-5	2013	Furthermore, we identify pharmacogenomic correlations between specific variants in genes such as TP53, BRAF, ERBBs, and ATAD5 and anticancer agents such as nutlin, vemurafenib, erlotinib, and bleomycin showing one of many ways the data could be used to validate and generate novel hypotheses for further investigation.	Bleomycin	192-201	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	103-107